Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention, including compliance with current guidelines—data from the POLish Atrial Fibrillation (POL-AF) Registry

BACKGROUND: Although triple antithrombotic therapy (TAT) is recommended in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI), guidelines allow an option of dual antithrombotic therapy (DAT). This study assesses the everyday practice of 10 cardiology departmen...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cardiovasc Diagn Ther
Autors principals: Uziębło-Życzkowska, Beata, Krzesiński, Paweł, Maciorowska, Małgorzata, Gorczyca, Iwona, Jelonek, Olga, Wójcik, Maciej, Błaszczyk, Robert, Kapłon-Cieślicka, Agnieszka, Gawałko, Monika, Tokarek, Tomasz, Rajtar-Salwa, Renata, Bil, Jacek, Wojewódzki, Michał, Szpotowicz, Anna, Krzciuk, Małgorzata, Bednarski, Janusz, Bakuła-Ostalska, Elwira, Tomaszuk-Kazberuk, Anna, Szyszkowska, Anna, Wełnicki, Marcin, Mamcarz, Artur, Wożakowska-Kapłon, Beata
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7944221/
https://ncbi.nlm.nih.gov/pubmed/33708474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/cdt-20-839
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars